Joshua Gafford leads and manages all day-to-day engineering activities at EndoTheia. He is an expert in medical devices and surgical robotics, having spent his academic career developing next-generation devices and robotic systems for minimally invasive surgery. During his tenure at Vanderbilt University, Joshua led the submission of several NIH SBIR/STTR proposals; efforts which have resulted in four funded federal awards, two funded state awards, totaling $6.7M of non-dilutive seed funding for EndoTheia to date. Further, through his leadership at EndoTheia, the company has submitted 8 different patent applications to the USPTO. Joshua received his Ph.D from Harvard University, where his research focused on the development of modular robotic systems for therapeutic endoscopy. He is also a graduate of Massachusetts Institute of Technology and Stanford University.
Medical device OEMs continue to drive rapid innovation in the development of lifesaving and life enhancing technologies. To enable this progress, CDMOs must continually innovate, pushing the boundaries of precision, scalability, and cost efficiency to support OEM innovation and cost reduction objectives. In this panel discussion, subject matter experts from Nissha Medical Technologies and EndoTheia will explore advancements in guidewire free steering technologies, DfM, DfA, microtooling, micromolding, microautomation, and microsensor integration. These capabilities are expanding the clinical toolkit available to surgeons and physicians, enabling greater procedural precision, improved outcomes, and next generation minimally invasive solutions.